Modalis Therapeutics Corporation (JP:4883) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modalis Therapeutics Corporation has reported a non-operating income of 63 million yen from foreign exchange gains for the first half of 2024. This income is primarily due to favorable currency exchange rates impacting the company’s foreign currency assets and liabilities. Investors are directed to the detailed ‘Consolidated Financial Results’ for the specific impact of these gains on the company’s earnings.
For further insights into JP:4883 stock, check out TipRanks’ Stock Analysis page.